Latest Articles

Publication Date
Selinexor May Confer PFS Benefit in TP53 Wild-Type Endometrial Cancer - OncLive

Selinexor May Confer PFS Benefit in TP53 Wild-Type Endometrial Cancer OncLive

Published: Nov. 4, 2024, 8:08 p.m.
Overexpressed nicotinamide N‑methyltransferase in endometrial stromal cells induced by macrophages and estradiol contributes to cell proliferation in endometriosis - Nature.com

Overexpressed nicotinamide N‑methyltransferase in endometrial stromal cells induced by macrophages and estradiol contributes to cell proliferation in endometriosis Nature.com

Published: Nov. 3, 2024, 8:12 a.m.
Morning Extra: Endometrial Cancer Survivor - PHL17 Philadelphia

Morning Extra: Endometrial Cancer Survivor PHL17 Philadelphia

Published: Oct. 31, 2024, 2:53 p.m.
Beating the Odds: Hampton Bays Woman Defeats Aggressive Endometrial Cancer - 27east.com

Beating the Odds: Hampton Bays Woman Defeats Aggressive Endometrial Cancer 27east.com

Published: Oct. 30, 2024, 6:23 p.m.
MMR Status Doesn’t Impact Outcomes of Chemo in Endometrial Cancer - Cancer Therapy Advisor

MMR Status Doesn’t Impact Outcomes of Chemo in Endometrial Cancer Cancer Therapy Advisor

Published: Oct. 29, 2024, 2:30 p.m.
Rapid increase of MFGE8 secretion from endometrial epithelial cells is an indicator of extracellular vesicle mediated embryo maternal dialogue - Nature.com

Rapid increase of MFGE8 secretion from endometrial epithelial cells is an indicator of extracellular vesicle mediated embryo maternal dialogue Nature.com

Published: Oct. 29, 2024, 7:03 a.m.
Can Pembrolizumab Improve dMMR Endometrial Cancer Outcomes? - Medscape

Can Pembrolizumab Improve dMMR Endometrial Cancer Outcomes? Medscape

Published: Oct. 28, 2024, 1:14 p.m.
Identification of key genes associated with endometriosis and endometrial cancer by bioinformatics analysis - Frontiers

Identification of key genes associated with endometriosis and endometrial cancer by bioinformatics analysis Frontiers

Published: Oct. 28, 2024, 10:28 a.m.
Endometrial Ablation Equipment Market Overall Study Report - openPR

Endometrial Ablation Equipment Market Overall Study Report openPR

Published: Oct. 28, 2024, 6:27 a.m.
Brachytherapy With Modified Rotte-y Applicator for Inoperable Endometrial Cancer: A Case Report - Cureus

Brachytherapy With Modified Rotte-y Applicator for Inoperable Endometrial Cancer: A Case Report Cureus

Published: Oct. 27, 2024, 7:49 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!